Skip to content

SLSN SLSN Cash & Equivalents

Cash & Equivalents at other companies

Ashland logo
AshlandASH
$343M+104%
The Beauty Health Company logo
The Beauty Health CompanySKIN
$204.36M-45.2%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$198.65M-2.5%
Colgate-Palmolive logo
Colgate-PalmoliveCL
$1.34B+20.1%
Future Fuel logo
Future FuelFF
$22.37M-77.0%
e.l.f. Beauty logo
e.l.f. BeautyELF
$289.69M+94.8%

Other financials

Income statement

See full
Revenue$13.0M-11.4%
Gross profit$3.3M-1.3%
Operating income-$504.0K-297%
Net income-$766.0K-1,058%
EPS (diluted)-$0.01

Balance sheet

See full
Total debt$9.7M-3.3%
Total equity$17.0M+11.9%
Total assets$47.8M-16.2%

Cash flow

See full
Operating cash flow$1.5M+121%
CapEx$528.0K+497%
Free cash flow$989.0K+113%

Valuation

See full
Market cap$51.91M-83.9%
Enterprise value$61.08M-81.4%
P/E55×
P/S0.9×-4.1×

Profitability

See full
Gross margin26.5%-1.5pp
Operating margin1.3%-6.5pp
Net margin1.6%
FCF margin-20.1%

Returns & leverage

See full
Return on equity5.9%
Debt / equity0.6×-0.1×
Current ratio2.1×+1.0×

Where this comes from

Reported directly by SLSN in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: SLSN’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SLSN's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SLSN's cash & equivalents?
SLSN (SLSN) reported cash & equivalents of $573K in Q1 2026.
How has SLSN's cash & equivalents changed year-over-year?
SLSN's cash & equivalents decreased by 68.5% year-over-year, from $1.82M to $573K.
What is the long-term trend for SLSN's cash & equivalents?
Over 5 years (2020 to 2025), SLSN's cash & equivalents has grown at a 6.1% compound annual growth rate (CAGR), from $957K to $1.29M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.